Skip to main content

Advertisement

SpringerLink
Log in

Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Although patients with metastatic colorectal cancer (CRC) are often unable to undergo treatment after resection of primary tumors, identifying such patients before surgery is not easy. In this study, we evaluated the association among clinicopathological findings, survival outcomes, and ability to undergo multimodal therapy after primary tumor resection in patients with Stage IV CRC.

Methods

We collected clinicopathological findings and preoperative laboratory data, including carcinoembryonic antigen (CEA) and systemic inflammatory response markers for 92 patients who were treated for Stage IV CRC between 2005 and 2014. We used multivariate analysis on factors that affect prognosis and ability to undergo postoperative treatment.

Results

Postoperative multimodal therapy improved overall survival (OS) significantly. Among serum markers, elevated CEA, neutrophil-to-lymphocyte ratio, and modified Glasgow prognosis score (mGPS) were significant indicators of shorter OS. In multivariate analysis, low performance status (P = 0.003), undifferentiated histology type (P = 0.019), and elevated mGPS (P = 0.042) were independent predictors of worse prognosis; and older age (P = 0.016), right-sided colon cancer (P = 0.043), and elevated mGPS (P = 0.031) were independent risk factors for difficulty of introducing postoperative multimodal therapy.

Conclusions

Preoperative mGPS is a useful objective indicator for CRC patients with multiple metastases who are able to undergo primary site resection followed by postoperative multimodal therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

    Article  CAS  PubMed  Google Scholar 

  2. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29

    Article  PubMed  Google Scholar 

  3. Cook AD, Single R, McCahill LE (2005) Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 12:637–645

    Article  PubMed  Google Scholar 

  4. van der Pool AE, Damhuis RA, Ijzermans JN et al (2012) Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis 14:56–61

    Article  PubMed  Google Scholar 

  5. van der Geest LG, Lam-Boer J, Koopman M et al (2015) Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis 32:457–465

    Article  PubMed  Google Scholar 

  6. Cirocchi R, Trastulli S, Abraha I et al (2012) Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev 8(8):CD008997. doi:10.1002/14651858.CD008997.pub2

    Google Scholar 

  7. Rahbari NN, Lordick F, Fink C et al (2012) Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS–a randomised controlled multicentre trial (ISRCTN30964555). BMC Cancer 12:142–151

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lam-Boer JT, Van der Geest LG, Verhoef C et al (2016) Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: a nationwide population-based propensity-score adjusted study in the Netherlands. Int J Cancer 139:2082–2094

    Article  PubMed  Google Scholar 

  9. Faron M, Pignon JP, Malka D et al (2015) Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials. Eur J Cancer 51:166–176

    Article  PubMed  Google Scholar 

  10. Ahmed S, Leis A, Chandra-Kanthan S et al (2016) Surgical management of the primary tumor in stage iv colorectal cancer: a confirmatory retrospective cohort study. J Cancer 7:837–845

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ahmed S, Leis A, Fields A et al (2014) Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study. Cancer 120:683–691

    Article  PubMed  Google Scholar 

  12. Wilkinson KJ, Chua W, Ng W et al (2010) Management of asymptomatic primary tumours in stage IV colorectal cancer: review of outcomes. World J Gastrointest Oncol 7:513–523

    Google Scholar 

  13. Stillwell AP, Buettner PG, Ho YH (2010) Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg 34:797–807

    Article  CAS  PubMed  Google Scholar 

  14. Watanabe T, Itabashi M, Shimada Y et al (2015) Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol 20:207–239

    Article  PubMed  PubMed Central  Google Scholar 

  15. Uratani R, Toiyama Y, Shimura T et al (2015) Preoperative lower body mass index correlates with poorer prognosis in patients undergoing curative laparoscopic surgery for colorectal cancer. Anticancer Res 35:5639–5648

    CAS  PubMed  Google Scholar 

  16. Toiyama Y, Hiro J, Shimura T et al (2016) The impact of body mass index on oncological outcomes in colorectal cancer patients with curative intent. Int J Clin Oncol 21(6):1102–1110

    Article  PubMed  Google Scholar 

  17. Toiyama Y, Inoue Y, Kawamura M et al (2015) Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery. Int Surg 100:199–207

    Article  PubMed  PubMed Central  Google Scholar 

  18. Mori K, Toiyama Y, Saigusa S et al (2015) Systemic analysis of predictive biomarkers for recurrence in colorectal cancer patients treated with curative surgery. Dig Dis Sci 60:2477–2487

    Article  CAS  PubMed  Google Scholar 

  19. Inoue Y, Iwata T, Okugawa Y et al (2013) Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology 84:100–107

    Article  CAS  PubMed  Google Scholar 

  20. Toiyama Y, Miki C, Inoue Y et al (2011) Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med 2:95–101

    PubMed  Google Scholar 

  21. Hu H, Krasinskas A, Willis J (2011) Perspectives on current tumor-node-metastasis (TNM) staging of cancers of the colon and rectum. Semin Oncol 38:500–510

    Article  PubMed  Google Scholar 

  22. Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655

    Article  CAS  PubMed  Google Scholar 

  23. McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12:223–226

    Article  PubMed  Google Scholar 

  24. Chiang SF, Hung HY, Tang R et al (2012) Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? Int J Colorectal Dis 27:1347–1357

    Article  PubMed  Google Scholar 

  25. Kwon HC, Kim SH, Oh SY et al (2012) Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 17:216–222

    Article  CAS  PubMed  Google Scholar 

  26. Ishizuka M, Nagata H, Takagi K et al (2012) Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer. J Surg Oncol 106:887–891

    Article  PubMed  Google Scholar 

  27. Damjanov N, Weiss J, Haller DG (2009) Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease. Oncologist 14:963–969

    Article  PubMed  Google Scholar 

  28. McMillan DC (2013) The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39:534–540

    Article  PubMed  Google Scholar 

  29. Proctor MJ, Morrison DS, Talwar D et al (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 47:2633–2641

    Article  PubMed  Google Scholar 

  30. Canna K, McArdle PA, McMillan DC et al (2005) The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92:651–654

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. McMillan DC, Canna K, McArdle CS (2003) Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90:215–219

    Article  CAS  PubMed  Google Scholar 

  32. Miki C, Konishi N, Ojima E et al (2004) C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci 49:970–976

    Article  CAS  PubMed  Google Scholar 

  33. Delmore G (1997) Assessment of nutritional status in cancer patients: widely neglected? Support Care Cancer 5:376–380

    Article  CAS  PubMed  Google Scholar 

  34. McMillan DC, Scott HR, Watson WS et al (1998) Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer 31:101–105

    Article  CAS  PubMed  Google Scholar 

  35. McMillan DC, Watson WS, O’Gorman P et al (2001) Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39:210–213

    Article  CAS  PubMed  Google Scholar 

  36. McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67:257–262

    Article  PubMed  Google Scholar 

  37. McMillan DC, Crozier JE, Canna K et al (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22:881–886

    Article  PubMed  Google Scholar 

  38. Ishizuka M, Nagata H, Takagi K et al (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246:1047–1051

    Article  PubMed  Google Scholar 

  39. Ishizuka M, Nagata H, Takagi K et al (2013) Inflammation-based prognostic system predicts survival after surgery for stage IV colorectal cancer. Am J Surg 205:22–28

    Article  PubMed  Google Scholar 

  40. Kishiki T, Masaki T, Matsuoka H et al (2013) Modified Glasgow prognostic score in patients with incurable stage IV colorectal cancer. Am J Surg 206:234–240

    Article  PubMed  Google Scholar 

  41. Maeda K, Shibutani M, Otani H et al (2013) Prognostic value of preoperative inflammation-based prognostic scores in patients with stage IV colorectal cancer who undergo palliative resection of asymptomatic primary tumors. Anticancer Res 33:5567–5573

    PubMed  Google Scholar 

  42. Adachi T, Hinoi T, Hattori M et al (2015) The modified Glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer. Surg Today 45:1396–1403

    Article  PubMed  Google Scholar 

  43. Kobayashi S, Karube Y, Nishihira M et al (2016) Usefulness of inflammation-based prognostic score in patients undergoing lung metastasectomy for colorectal carcinoma. World J Surg 40:1632–1637

    Article  PubMed  Google Scholar 

  44. Shibutani M, Maeda K, Nagahara H et al (2015) Significance of markers of systemic inflammation for predicting survival and chemotherapeutic outcomes and monitoring tumor progression in patients with unresectable metastatic colorectal cancer. Anticancer Res 35:5037–5046

    PubMed  Google Scholar 

  45. Kuijpers CC, Sluijter CE, von der Thusen JH et al (2016) Interlaboratory variability in the histologic grading of colorectal adenocarcinomas in a nationwide cohort. Am J Surg Pathol 40:1100–1108

    Article  PubMed  Google Scholar 

  46. Petrelli F, Tomasello G, Borgonovo K et al (2016) Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncol. doi:10.1001/jamaoncol.2016.4227

    Google Scholar 

  47. Yahagi M, Okabayashi K, Hasegawa H et al (2016) The worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysis. J Gastrointest Surg 20:648–655

    Article  PubMed  Google Scholar 

  48. Nitsche U, Stogbauer F, Spath C et al (2016) Right sided colon cancer as a distinct histopathological subtype with reduced prognosis. Dig Surg 33:157–163

    Article  PubMed  Google Scholar 

  49. Ishihara S, Nishikawa T, Tanaka T et al (2014) Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study. Int J Surg 12:925–930

    Article  PubMed  Google Scholar 

  50. Chan M, Hugh-Yeun K, Gresham G et al (2016) Population-based patterns and factors associated with underuse of palliative systemic therapy in elderly patients with metastatic colon cancer. Clin Colorectal Cancer. doi:10.1016/j.clcc.2016.08.004

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Graduate School of Medicine, Mie University, Mie, 514-8507, Japan

    Tadanobu Shimura, Yuji Toiyama, Susumu Saigusa, Hiroki Imaoka, Masato Okigami, Hiroyuki Fujikawa, Junichiro Hiro, Minako Kobayashi, Masaki Ohi, Toshimitsu Araki, Yasuhiro Inoue, Keiichi Uchida, Yasuhiko Mohri & Masato Kusunoki

Authors
  1. Tadanobu Shimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuji Toiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susumu Saigusa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroki Imaoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masato Okigami
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroyuki Fujikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Junichiro Hiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Minako Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Masaki Ohi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Toshimitsu Araki
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yasuhiro Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Keiichi Uchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yasuhiko Mohri
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Masato Kusunoki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tadanobu Shimura.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to disclose.

Electronic supplementary material

Below is the link to the electronic supplementary material.

10147_2017_1113_MOESM1_ESM.ppt

Supplemental Figure 1 Modified GPS score against histological differentiation. The mGPS2 group had a significantly higher percentage of poorly differentiated histological type (7/20, 35%) than the mGPS0/1 group (6/72, 8.3%, P = 0.0054). Supplemental Figure 2 Histological differentiation against NLR values. The poor histology group had significantly higher median preoperative NLR (5.53, range 0.96–17.71) than the well/moderate histology group (2.98, range 0.57–30.13; P = 0.0332). Supplemental Figure 3 Patient age in relation to whether or not they underwent postoperative treatment. Median age in the untreated group (75 years; range 59–90 years) was significantly older than in the treated group (63 years, range 31–84 years; P = 0.0002) (PPT 194 kb)

Supplementary material 2 (DOCX 23 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shimura, T., Toiyama, Y., Saigusa, S. et al. Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases. Int J Clin Oncol 22, 758–766 (2017). https://doi.org/10.1007/s10147-017-1113-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-017-1113-2

Keywords

Search

Navigation